| MSF India Skip to main content

Popup Login

  • HR Login
  • Sara Login
  • Login

Search

Enter the terms you wish to search for.
Home

Footer

  • About Us
    • What is MSF
    • Where We Work
    • What We Do
    • Our Publications
    • Finances
  • MSF in India
    • Projects In India
    • Access Campaign
  • News & Stories
    • News From Our Projects
    • Stories From The Field
    • Statements & Opinions
    • Medical Research
    • Press Room
  • Get Involved
    • Individual Support
    • Corporate Support
    • Fundraise For MSF
    • Events
    • Campaigns
    • Donation Faq
    • Donor Stories

Work with us

  • Work with us
    • Work Overseas
    • Work in India (Projects)
    • Work in India (Office)
    • GHHM Course
  • Donate

Footer

  • About Us
    • What is MSF
    • Where We Work
    • What We Do
    • Our Publications
    • Finances
  • MSF in India
    • Projects In India
    • Access Campaign
  • News & Stories
    • News From Our Projects
    • Stories From The Field
    • Statements & Opinions
    • Medical Research
    • Press Room
  • Get Involved
    • Individual Support
    • Corporate Support
    • Fundraise For MSF
    • Events
    • Campaigns
    • Donation Faq
    • Donor Stories

HIV, multidrug-resistant TB and depressive symptoms:when three conditions collide

HIV, multidrug-resistant TB and depressive symptoms:when three conditions collide

September 01, 2014

Related
  • Universal health coverage in a regional Nepali hospital
    March 21, 2013
  • Post Kala-Azar Dermal Leishmaniasis following treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) for Primary Visceral Leishmaniasis in Bihar, India
    January 01, 2014
  • Risk factors for Visceral Leishmaniasis relapse in Immunocompetent patients following treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India
    January 01, 2014
  • Five-year field results and long-term effectiveness of 20 mg/kg Liposomal Amphotericin B (Ambisome) for Visceral Leishmaniasis in Bihar, India
    January 01, 2014
  • HIV, multidrug-resistant TB and depressive symptoms:when three conditions collide
    September 01, 2014
  • Kashmir Mental Health Survey
    January 01, 2016
  • TB Briefing Paper - October 2016
    October 01, 2016

Share

  • Facebook
  • Twitter
  • Googleplus
  • LinkedIn
  • Instagram

Footer

  • About Us
    • What is MSF
    • Where We Work
    • What We Do
    • Our Publications
    • Finances
  • MSF in India
    • Projects In India
    • Access Campaign
  • News & Stories
    • News From Our Projects
    • Stories From The Field
    • Statements & Opinions
    • Medical Research
    • Press Room
  • Get Involved
    • Individual Support
    • Corporate Support
    • Fundraise For MSF
    • Events
    • Campaigns
    • Donation Faq
    • Donor Stories

Reach Us

+91 11 49010000

india.info@new-delhi.msf.org

MSF India, AISF Building, First floor, Amar Colony, Lajpat Nagar-IV, New Delhi-110024, India

Reach Us

+91 11 49010000

india.info@new-delhi.msf.org

MSF India, AISF Building, First floor, Amar Colony, Lajpat Nagar-IV, New Delhi-110024, India

Follow Us

  • Facebook
  • Twitter
  • LinkedIn
  • Youtube
  • Instagram
  • Googleplus
  • Rss

MSF India

Privacy Policy Disclaimer  Sitemap
Copyright © Médecins Sans Frontières India. All Rights Reserved.